Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company has developed a Peptide Docking Vehicle (PDoV™)...
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the...
Inhibrx, Inc., a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the European Commission ("EC"), based on...
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that, in conjunction with its partner...
STEER Technologies Inc., an integrated ESG technology platform, is pleased to announce its electric vehicle subscription service (“STEER EV”) has obtained a business license...
